WO1993025898A1 - Mediators to oxidoreductase enzymes - Google Patents

Mediators to oxidoreductase enzymes Download PDF

Info

Publication number
WO1993025898A1
WO1993025898A1 PCT/GB1993/001179 GB9301179W WO9325898A1 WO 1993025898 A1 WO1993025898 A1 WO 1993025898A1 GB 9301179 W GB9301179 W GB 9301179W WO 9325898 A1 WO9325898 A1 WO 9325898A1
Authority
WO
WIPO (PCT)
Prior art keywords
ligand
compound
group
transition metal
sandwich
Prior art date
Application number
PCT/GB1993/001179
Other languages
French (fr)
Inventor
Nigel Forrow
Stephen Walters
Original Assignee
Medisense, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medisense, Inc. filed Critical Medisense, Inc.
Priority to EP93913284A priority Critical patent/EP0598095A1/en
Priority to JP50123994A priority patent/JP3288044B2/en
Publication of WO1993025898A1 publication Critical patent/WO1993025898A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/004Enzyme electrodes mediator-assisted

Definitions

  • the present invention relates to mediators to oxidoreductase enzymes.
  • the present invention relates to such mediators for use m amperometric enzyme electrodes.
  • Amperometric enzyme electrodes are described, for example, in BIOSENSORS Fundamentals and Applications, edited by Turner, Karube and Wilson, Oxford University Press (1987). The reader is referred to this book for background reading.
  • Electrode communication between an electrode and the active site of a redox enzyme is a key feature of amperometric enzyme electrodes.
  • this has been achieved using low molecular weight, rapidly diffusing mediators with fast redox couples.
  • Organic compounds such as phenazine methosulphate, 2,6-dichloroindophenol, quinones and phenylene diamines were among the first such species to be used in conjunction with glucose oxidase (GOD).
  • GOD glucose oxidase
  • these compounds suffer from a number of problems which include poor stability and pH-dependent redox potentials.
  • inorganic mediators suffer from the problem that it is not easy to modify their redox potentials and/or aqueou solubility.
  • the field of inorganic mediators has been ext_ ;>' d by ferrocenes, which are sandwich compounds with an iron atom sandwiched between two ⁇ -bonding cyclopentadienyl rings.
  • the access to a large number of derivatives means that the properties of ferrocenes can readily be modified by substitution on one or both of the cyclopentadienyl rings.
  • Ferrocene mediators have been shown to undergo rapid electron transfer with oxidoreductase enzymes such as glucose oxidase (Anal. Chem., 56
  • a principal object of the present invention is the provision of compounds of use as mediators for oxidoreductase enzymes or other electron transfer redox proteins.
  • Related objects include mediation processes employing such mediators, products based on the mediation processes, manufacturing methods for the mediated products, and compositions containing the mediators.
  • ⁇ -ligand which may be allyl, cyclopropenyl, cyclobutadiene, cyclopentadienyl, benzene, cycloheptatrienyl or trimethylenemethane, among others
  • oxidoreductase enzymes such as glucose oxidase
  • the mediating function is not restricted to enzymes, and may be used with other electron transfer redox proteins.
  • the present invention provides transition metal half-sandwich complexes, for use as mediators in electron transfer between enzymes and electrodes.
  • the present invention provides a process for mediating electron transfer between an oxidoreductase enzyme and an electrode, which is characterised by the use of a transition metal half- sandwich compound as mediator.
  • a transition metal half- sandwich compound as mediator.
  • the present invention provides mediated enzyme products and methods of manufacturing such products.
  • the present complexes can be used in the manufacture of amperometric enzyme sensors, such as those of the kind described in EP-78636-A, EP 125136- A, EP 125137-A, EP 125139-A, EP 125867-A, EP 127958-A or EP 230786-A, but using a transition metal half-sandwich compound as mediator.
  • the present invention provides amperometric enzyme sensors of use for testing for the presence of an analyte in a sample, especially an aqueous sample.
  • the sample can be a complex biological sample, for instance a biological fluid such as whole blood, plasma or serum, and the analyte can be a naturally occurring metabolite such as glucose or cholesterol, or an introduced substance such as a drug.
  • the present invention further provides an electrically conductive printing ink which includes a transition metal half-sandwich mediator compound.
  • a central feature of the invention is the use as a redox mediator for oxidoreductase enzymes of a half-sandwich complex where a single ⁇ -ligand is bonded to a transition metal ion complexed by other ligands.
  • the single ⁇ -ligand will comprise 3 or more atoms, typically 3 to 7 atoms, which will generally be carbon but can include any heteroatom capable of ⁇ bonding including nitrogen, oxygen, sulphur and phosphorus.
  • at least three interlinked atoms of the ⁇ -ligand define a plane with delocalised ⁇ bonding and which interact directly with the transition metal atom.
  • transition metal ion is not critical, except for the ability to undergo rapid electron transfer.
  • identity of the other ligands is not critical, except that they are not ⁇ -bonding.
  • the other ligands may be chosen from any of carbonyl, phosphine, isocyanide, nitrosyl, bipyridine, phenanthroline or dithiolate.
  • the half-sandwich compound for use as mediator is a complex of the general formula:
  • ( ⁇ -ligand)M(not- ⁇ -ligand) n wherein the complex may be charged or neutral, ⁇ -ligand represents the single ⁇ -bonded ligand, represents the transition metal atom, n is the number of ligands which are not ⁇ -ligands, and the n not- ⁇ -ligands are the same or different, are univalent or multivalent, and serve to satisfy the valency of the transitional metal M.
  • the ⁇ -ligand is selected from ⁇ -ligands with 3 to 7 carbon atoms, and is most preferably an allyl, cyclopropenyl, cyclobutadiene, cyclopentadienyl, benzene, cycloheptatrienyl or trimethylenemethane group.
  • the ⁇ -ligand can be unsubstituted, but is preferably a substituted ligand.
  • the nature of the substituent is not critical, since it is a feature of the present invention that variation in the identity of the substituent allows the preparation of compounds with different properties for assessment as candidate mediators. Purely by way of illustration, there can be 1 or more, usually 1 to 4, substituents.
  • Such substituents may be selected from alkyl groups, especially a methyl or ethyl group; alkoxy groups, especially a methoxy or ethoxy group; amino and substituted amino groups, especially an amino, dimethylamino, diethylamino or di( ⁇ -hy ⁇ _roxyethyl)amino group; aminoalkyl and substituted aminoalkyl groups, especially an aminomethyl or dimethylaminomethyl group; a carboxylic acid group; or a suiphonic acid group.
  • the transition metal M is preferably iron, manganese or chromium.
  • Each not- ⁇ -ligand is preferably selected from carbonyl, phosphine, isocyanide, nitrosyl, bipyridine, phenanthroline or dithiolate groups.
  • the transition metal half-sandwich compound is employed as an inclusion complex in ⁇ -cyclodextrin, which typically takes the form of a 1 : 1 adduct.
  • the transition metal half-sandwich compounds are generally known or can be made by modified literature methods.
  • transition metal half-sandwich complexes over the ferrocenes is that the greater degree of structural possibilities allows their properties to be tailored more closely to fit a particular enzyme application and/or biosensor configuration.
  • Other applications and advantages of the present invention will be apparent, such as the possibility of the use of transition metal half-sandwich complexes as mediators to oxidoreductase enzymes, such as the generality of the flavoprotein, metalloprotein and quinoprotein oxidoreductases; also to act as mediators to redox proteins such as haemoglobin or to respiratory or other electron transfer redox proteins; the possibility of their use as labels for antigens or antibodies in immunochemical procedures including such as described in EP 125139-A; the possibility of their use as artificial substrates to monitor enzyme reactions with redox potentials modified by reaction with the enzyme; the possibility of tailoring the redox potential of a mediator by careful choice of ligands such that it may interact with a particular oxidoreductase protein but not with
  • the preferred amperometric enzyme sensor adopting a transition metal half- sandwich compound as mediator utilizes a strip test element, especially a throw-away dry strip.
  • a disposable test element carries a working electrode, the test reagents comprising at least the oxidoreductase enzyme and transition metal half-sandwich mediator compound for generation of a current indicative of the level of analyte, and a reference electrode.
  • the test reagents are in one or more carbon-based layers associated with the working electrode.
  • the sensor electrodes preferably comprise electrode areas formed for instance by screen printing, spraying, or other suitable deposition technique.
  • the present invention provides a dry strip sensor which comprises an elongate, electrically-insulating carrier having a pair of longitudinal, substantially parallel electrically-conducting tracks thereupon, each track being provided at the same end with i.. « ⁇ ans for electrical connection to a read-out means and provided with an electrode, one of the electrodes being the reference electrode and the other being the working electrode, together with test reagents.
  • such a sensor is configured in the form of a supporting strip of electrically insulating carrier material such as a synthetic polymer (for instance pvc) carrying at a location between its ends the two electrodes supported on electrically conductive printed tracks.
  • the electrodes can take the form of two rectangular areas side by side on the carrier strip. Such areas can be configured as a target area to be covered by a single drop of sample, such as whole blood, for testing for an analyte.
  • non-rectangular electrode areas for instance diamond-shaped, semicircular, or triangular areas, can be employed to provide a target area for optimised contact by a liquid sample.
  • the carrier carries at least two electrodes, namely a reference electrode and a working electrode, but may carry further electrodes such as a counter electrode and/or a dummy electrode, which is of similar formulation to the working electrode with associated test reagents, but lacks one or more of its active components.
  • a dummy third electrode can lead to more reliable results, in that if charge passed at the third electrode is subtracted from charge passed at the working electrode, then the resulting charge is solely due to the reaction of interest.
  • a membrane may be provided at and above the target to perform a filtration function, for example to filter blood cells from the sample before it enters the test strip.
  • a filtration or cellular separation membrane might be cast in situ.
  • a single use disposable electrode strip for attachment to signal readout circuitry of a sensor system to detect a current representative of a compound in a liquid mixture
  • the strip comprising: a) an elongated support adapted for releasable attachment to the readout circuitry; b) a first conductor extending along the support and comprising a conductive element for connection to the readout circuitry; c) an active electrode on the strip in contact with the first conductor and positioned to contact the mixture, the active electrode comprising a printed layer on the support, the printed layer comprising an enzyme capable of catalyzing a reaction involving a substrate for the enzyme and a transition metal half-sandwich mediator capable of transferring electrons transferred between the enzyme-catalyzed reaction and the first conductor to create a current representative of the activity of the enzyme and representative of the compound, the printed layer having an area less than 25 square mm; d) a second conductor extending along the support, comprising a conductive element
  • test strips of this invention can detect analytes for example by known mediated enzyme electrochemical reactions, but using a transition metal half-sandwich compound as mediator.
  • the reader is referred to European Patent 78636-A, especially for its mention of glucose oxidase, as well as European Patent 127958-A and European Patent Specification 125137-A.
  • mediators for use with the present mediators include combinations of cholesterol oxidase, a peroxidase and optionally cholesterol esterase, for detection of free or total cholesterol, as described in European Patent 230786-A; and more generally systems including oxidoreductase or other enzymes, including flavoproteins, quinoproteins, and metalloproteins, and one or more mediator compounds, for example as described in European Patent Specification 125137-A.
  • enzyme systems suitable for use in devices according to the present invention include oxidoreductases using nicotinamide and adenine dinucleotide and nicotinamide adenine dinucleotide phosphate as cofactors, for example those described in European Patent 125867-A; or systems using more than one enzyme, as described in European Patent 125136- A.
  • Test strips according to this invention are intended for use with electronic apparatus and meter systems. These control the progress of the electrochemical reaction, for example by maintaining a particular potential at the electrodes, and monitor the reaction and calculate and present the result.
  • a particular feature which is desirable in a meter system for use with test strips of this type is the capability to detect the wetting of the reaction zone by sample fluid; this allows timely initiation of the measurement and reduces the scope for inaccuracies caused by user error. It is possible to achieve this goal by applying a potential to the electrodes of the test strip as soon as it is inserted into the meter; this potential is maintained until a certain threshold current is measured which will reflect the wetting of the reaction zone by sample fluid. The potential may then be removed for a short time to allow wetting to V completed before initiation of measurement in the usual way.
  • a further feature which is advantageous is the facility to ascertain automatically the identity of test strips for the measurement of different analytes. This might be achieved, for example, by the provision of additional contacts on the test strip in a pattern characterising the type of strip; the meter would have contact pads to determine the presence or absence of each contact.
  • a system is possible using one or more additional circuit loops printed on the test strip of determined resistance characteristic of the type of strip, as described in US 5126034 at column 4, lines 3 to 17.
  • notches or other shapes might be made in the proximal end of the test strip which is inserted into the meter; switches or optical detectors in the meter can detect the presence or absence of each notch.
  • Further possibilities for recognition of strip types include varying the colour of the strips and providing the meter with a photodetector capable of distinguishing the range of colours; also providing the strips with barcodes; magnetic stripes or other markings and providing the meter with a suitable reading arrangement.
  • the strip electrodes have a three-electrode configuration comprising a reference electrode, a working electrode, and a dummy electrode.
  • the carrier can be made from any material which has an electrically insulating surface including poly(vinyl chloride), polycarbonate, polyester, paper, cardboard, ceramic, metal coated with ceramic or other insulating substance.
  • poly(vinyl chloride) or a blend of polycarbonate/polyester seems to be particularly suitable.
  • a sheet of carrier material is cut to size using a punch tool which crops the outer edges at the same time as punching a number of registration holes. It is advantageous to use these holes during subsequent operations, but it is also feasible to edge-register throughout the process.
  • a conductive ink is applied to the carrier by a method of deposition such as screen printing.
  • the punched holes are used to register the carrier.
  • This layer produces the contact areas which allow a meter to interface with the test strip and provides an electrical circuit between the contacts and the active chemistry occurring on the strip.
  • the ink is an organic solvent-based carbon mixture which is air-dried.
  • Alternative formulations are possible including water-based inks and silver inks. Other methods of drying or curing the inks include infra-red, ultra-violet and radio- frequency radiation.
  • a layer forming the reference electrode is then printed with an organic solvent-based ink containing a silver/silver chloride mixture.
  • the print extends to partially cover the middle track of the carbon print where it extends into the reaction zone. It is useful if separate parts of this print are extended to cover parts of the other carbon tracks outside the reaction zone so that the total electrical resistance of each track is reduced.
  • a layer of dielectric ink may optionally be printed to cover the majority of the printed carbon and silver/silver chloride layers. In this case, two areas are left uncovered, namely the electrical contact areas and the sensing area which will underlie the reactive zone. This print serves to define the area of the reactive zone, and to protect exposed tracks from short circuit.
  • one or more inks are deposited to a precise thickness within a defined area on top of one of the conductive tracks within the reaction zone, to deposit the enzyme and the half-sandwich mediator compound. It is convenient to do this by means of screen printing. Other ways of laying down this ink include inkjet, volumetric dosing, gravure printing, flexographic printing, and letterpress printing.
  • a second partially active ink forming a dummy electrode can be deposited on a remaining conductive track, such that each active ink lies on a conducting track equidistant from a central track coated with the silver/silver chloride ink.
  • the phosphate buffer solution (PBS) of 0.15 M phosphate (with 0.2 M sodium chloride as supporting electrolyte), pH 7.0, containing 0.1 M glucose was prepared using Analar reagents from Merck BDH. The solution was stored overnight at 4°C prior to use to allow equilibration of the - and ⁇ - anomers.
  • Glucose oxidase (EC 1.1.3.4 from Aspergillus niger) was supplied by Sturge Enzymes. Horseradish peroxidase was obtained from Biozyme.
  • Figure 2 comprises (a) cyclic voltammograms of electrodes containing the chromium complex Compound 6, and (b) the catalytic wave upon addition of glucose oxidase.
  • Figure 3 shows catalytic waves obtained on titrating glucose oxidase with the manganese complex Compound 8.
  • Figure 4 is a graphical plot of data obtained from the catalytic waves of Figure 3.
  • Figure 5 is a cyclic voltammogram of the manganese complex Compound 16.
  • Figure 8 comprises cyclic voltammograms of electrodes containing the manganese complexes (a) Compound 10, (b) Compound 1 1 , and (c) Compound 12.
  • Figure 9 comprises (a) cyclic voltammograms of electrodes containing the manganese complex Compound 10, and (b) the catalytic wave upon addition of glucose oxidase.
  • Figure 10 shows the response to glucose of poised glucose oxidase/Compound 10 electrodes.
  • Example 2 The half wave potential of benzene chromium tricarbonyl has been recorded as +710mV vs SCE in dichloromethane (J. Chem Soc. Dalton Trans., (1973) 1768). This complex has negligible solubility in buffer. Derivatives, however, are simple to prepare in good yield using the thermolysis of chromium hexacarbonyl with substituted benzenes in tetrahydrofuran/di-n- butyl ether (Inorg. Synth., 19 (1979) 154). Arenes containing amines directly attached to the ring were selected in the hope of enhancing the aqueous solubility of the resulting complexes as well as reducing their mid ⁇ point potentials. A series of seven complexes were investigated and were found to demonstrate aqueous electrochemistry in the region +280 to +40mV, as shown in the following table.
  • Figure 1 is a cyclic voltammogram of th , . romium complex Compound 6, at 50 mV/s in PBS.
  • Compound 6 was - . only compound to display a reversible wave, as shown Figure 1, though it was poorly soluble in aqueous buffer. Further studies were confined to Compound 6.
  • Manganese half-sandwich complexes can be obtained from (methylcyclopentadienyl)manganese tricarbonyl Compound 8, an inexpensive and readily available starting material due to its large scale use as an anti-knocking additive in unleaded petrol.
  • access to a wide and varied carbonyl substitution chemistry is provided via the nitrosyl cation Compound 9 produced by treatment of the tricarbonyl compound Compound 8 with nitrous acid (Inorg. Chem., 6 (1967) 469) or nitrosonium ion (J. Organomet. Chem, 56 (1973) 345).
  • Cyclopentadienyl manganese tricarbonyl itself is more difficult to oxidise than ferrocene; its oxidation potential being some 1.2 V more positive than ferrocene in acetonitrile (J. Organomet. Chem., 101 (1975) C43).
  • the nitrosyl cation Compound 9 readily decomposes in aqueous buffer to give a species which is irreversibly oxidized at +230 mV.
  • treatment of Compound 8 with cyanide ion (J. Organomet. Chem., 170 (1979) 217) affords the anionic dicyano complex Compound 13 which is highly water soluble and displays a reversible wave at +440 mV.
  • Compound 16 was prepared from cis-l,2-dicyanoethylene-l,2-dithiolate (Inorg. Chem., 8 (1969) 1340).
  • Figure 5 is a cyclic voltammogram of the manganese complex Compound 16 0.6 mM in PBS at 50 mV/s and 2 ⁇ A/cm. A much lower E ox of -25 mV was observed for the anionic dithiolene complex, but the oxidized form (a neutral species) proved to be insoluble in buffer. The resultant coating of the electrode meant that an enzyme titration was not possible.
  • Figure 6 comprises (a) a cyclic voltammogram of the ⁇ -cyclodextrin adduct of the manganese complex Compound 10 in 0.1 M glucose/PBS, and (b) the catalytic wave upon addition of 50 ⁇ l glucose oxidase.
  • ⁇ -cd is capable of hosting a neutral manganese half sandwich complex
  • ⁇ -cd might act as a solubilising agent for the insoluble oxidized form of the anionic complex Compound 16 mentioned earlier.
  • the cyclic voltammogram of a 0.5 mM solution of Compound 16 in buffer has features which indicate that a species is being precipitated onto the electrode.
  • addition of ⁇ -cd (0.5- 5.0mM) resulted in a reversible wave.
  • Figure 7 comprises cyclic voltammograms of the manganese complex Compound 16 in the presence of different amounts of (a) PBS only, and PBS containing (b) 0.5 mM ⁇ -cd, (c) 1.0 mM ⁇ -cd, and (d) 5.0 mM ⁇ -cd.
  • mediator/enzyme electrodes responded linearly as shown in Figure 10 to glucose in the range 0 to 12 mM when poised at +450 mV. Inclusion of ethylene glycol in the formulation of the carbon ink containing enzyme gave currents of up to 190 ⁇ A with 0.1 M glucose.
  • the catalytic ring current was then measured while poising the ring electrode at -100 mV and scanning the disk electrode from -100 to - 600m V to generate hydrogen peroxide. Successive experiments with the ferrocene and the ⁇ -cd adduct of Compound 10 resulted in identical catalytic currents being recorded.

Abstract

Half-sandwich complexes of transition metals having a single π-ligand with delocalised π bonding are of use in mediating electron transfer between an electrode and a redox protein, for example an oxidoreductase enzyme such as in an amperometric enzyme sensor. Suitable compounds include complexes of the general formula: (π-ligand)M(not-π-ligand)n, wherein the complex is charged or neutral, π-ligand represents the single π-bonded ligand, M represents the transition metal atom, n is the number of ligands which are not π-ligands, and the n not-π-ligands are the same or different, are univalent or multivalent, and serve to satisfy the valency of the transitional metal M.

Description

MEDIATORS TO OXIDOREDUCTASE ENZYMES
The present invention relates to mediators to oxidoreductase enzymes. In particular, the present invention relates to such mediators for use m amperometric enzyme electrodes.
BACKGROUND OF THE INVENTION
Amperometric enzyme electrodes are described, for example, in BIOSENSORS Fundamentals and Applications, edited by Turner, Karube and Wilson, Oxford University Press (1987). The reader is referred to this book for background reading.
Electrical communication between an electrode and the active site of a redox enzyme is a key feature of amperometric enzyme electrodes. Generally this has been achieved using low molecular weight, rapidly diffusing mediators with fast redox couples. Organic compounds such as phenazine methosulphate, 2,6-dichloroindophenol, quinones and phenylene diamines were among the first such species to be used in conjunction with glucose oxidase (GOD). However, these compounds suffer from a number of problems which include poor stability and pH-dependent redox potentials. These problems have been addressed through the use of inorganic species such as octacyanotungstate, hexacyanoferrate, hexacyanoruthenate, ruthenium amine complexes, osmium complexes, and metal po hyrins. Metal bipyridine and phenanthroline complexes have also been suggested.
Many of these inorganic mediators suffer from the problem that it is not easy to modify their redox potentials and/or aqueou solubility. In this respect the field of inorganic mediators has been ext_ ;>' d by ferrocenes, which are sandwich compounds with an iron atom sandwiched between two π-bonding cyclopentadienyl rings. The access to a large number of derivatives means that the properties of ferrocenes can readily be modified by substitution on one or both of the cyclopentadienyl rings.
Ferrocene mediators have been shown to undergo rapid electron transfer with oxidoreductase enzymes such as glucose oxidase (Anal. Chem., 56
(1987) 667); cholesterol oxidase (Electrochemical Sensors for Biomedical Applications, editor C.K.N. Lim, The Electrochem. Soc. (Proceedings Volume), 86-14 (1986) 16); sarcosine oxidase (J. Electroanal. Chem., 240
(1988) 33); lactate oxidase (J. Electroanal. Chem., 240 (1988) 33); pyruvate oxidase (J. Electroanal. Chem., 190 (1985) 1 17); xanthine oxidase (J. Electroanal. Chem., 190 (1985) 117); glutathione reductase (J. Electroanal. Chem., 190 (1985) 1 17); diaphorase (Electrochemical Sensors for Biomedical Applications, editor. C.K.N. Lim, The Electrochem. Soc. (Proceedings Volume), 86-14 (1986) 16); glucose dehydrogenase (Biosensors, 2 (1986) 71); and horseradish peroxidase (J. Electroanal. Chem., 201 (1986) 1).
Nevertheless, the need remains to expand the list of candidate mediator compounds, allowing new mediators to be developed with tailored properties suited to particular applications.
OBJECTS OF THE PRESENT INVENTION
A principal object of the present invention is the provision of compounds of use as mediators for oxidoreductase enzymes or other electron transfer redox proteins. Related objects include mediation processes employing such mediators, products based on the mediation processes, manufacturing methods for the mediated products, and compositions containing the mediators.
SUMMARY OF THE PRESENT INVENTION
It has now been found that complexes (half-sandwich complexes) of transition metals such as iron, manganese and chromium containing a single - _> -
π-ligand (which may be allyl, cyclopropenyl, cyclobutadiene, cyclopentadienyl, benzene, cycloheptatrienyl or trimethylenemethane, among others) are capable of mediating electron transfer to oxidoreductase enzymes such as glucose oxidase, with efficiencies comparable to the ferrocenes but offering the potential for more extensive substitution chemistry. The mediating function is not restricted to enzymes, and may be used with other electron transfer redox proteins.
There have been some reports on the electrochemistry of transition metal half-sandwich complexes, but not in the context of mediation to redox proteins. For example, the effect of substitution on the electrochemical oxidation in acetonitrile of cyclopentadienyltricarbonyl-manganese and - rhenium is reported in J. Organomet. Chem., 101 (1975) C43. The voltammetric oxidation in dichloromethane of arene, cycloheptatriene, and cycloheptatrienyl tricarbonyl complexes of chromium is reported in J. Chem. Soc. Dalton Trans., (1973) 1768. Cyclic voltammetry in acetonitrile of a cyclopentadienylmanganese derivative, a cycl eptatrienylmolybdenum derivative and a cyclopentadienyliron derivative is reported in J. Organomet. Chem., 170 (1979) 217. The voltammetric properties in dichloromethane of certain π-cyclopentadienylsulphur complexes of manganese, molybdenum, tungsten and cobalt are reported in Inorg. Chem., 8 (1969) 1340.
PREFERRED EMBODIMENTS OF HE INVENTION
In general, the present invention provides transition metal half-sandwich complexes, for use as mediators in electron transfer between enzymes and electrodes. Correspondingly, the present invention provides a process for mediating electron transfer between an oxidoreductase enzyme and an electrode, which is characterised by the use of a transition metal half- sandwich compound as mediator. We have found that such transition metal half-sandwich compounds can act as radiators in aqueous systems.
In another aspect, the present invention provides mediated enzyme products and methods of manufacturing such products. Illustratively the present complexes can be used in the manufacture of amperometric enzyme sensors, such as those of the kind described in EP-78636-A, EP 125136- A, EP 125137-A, EP 125139-A, EP 125867-A, EP 127958-A or EP 230786-A, but using a transition metal half-sandwich compound as mediator. The reader is referred to these published patent specifications, whose content is incorporated herein by reference. Accordingly, the present invention provides amperometric enzyme sensors of use for testing for the presence of an analyte in a sample, especially an aqueous sample. For example, the sample can be a complex biological sample, for instance a biological fluid such as whole blood, plasma or serum, and the analyte can be a naturally occurring metabolite such as glucose or cholesterol, or an introduced substance such as a drug.
Of particular utility for the manufacture of amperometric enzyme sensors, the present invention further provides an electrically conductive printing ink which includes a transition metal half-sandwich mediator compound.
A central feature of the invention is the use as a redox mediator for oxidoreductase enzymes of a half-sandwich complex where a single π-ligand is bonded to a transition metal ion complexed by other ligands. The single π-ligand will comprise 3 or more atoms, typically 3 to 7 atoms, which will generally be carbon but can include any heteroatom capable of π bonding including nitrogen, oxygen, sulphur and phosphorus. By definition in order to have π-bonding, at least three interlinked atoms of the π-ligand define a plane with delocalised π bonding and which interact directly with the transition metal atom. The nature of the transition metal ion is not critical, except for the ability to undergo rapid electron transfer. The identity of the other ligands is not critical, except that they are not π-bonding. For example, the other ligands may be chosen from any of carbonyl, phosphine, isocyanide, nitrosyl, bipyridine, phenanthroline or dithiolate.
Preferably, the half-sandwich compound for use as mediator is a complex of the general formula:
(π-ligand)M(not-π-ligand)n wherein the complex may be charged or neutral, π-ligand represents the single π-bonded ligand, represents the transition metal atom, n is the number of ligands which are not π-ligands, and the n not-π-ligands are the same or different, are univalent or multivalent, and serve to satisfy the valency of the transitional metal M.
More preferably, the π-ligand is selected from π-ligands with 3 to 7 carbon atoms, and is most preferably an allyl, cyclopropenyl, cyclobutadiene, cyclopentadienyl, benzene, cycloheptatrienyl or trimethylenemethane group. The π-ligand can be unsubstituted, but is preferably a substituted ligand. The nature of the substituent is not critical, since it is a feature of the present invention that variation in the identity of the substituent allows the preparation of compounds with different properties for assessment as candidate mediators. Purely by way of illustration, there can be 1 or more, usually 1 to 4, substituents. Such substituents may be selected from alkyl groups, especially a methyl or ethyl group; alkoxy groups, especially a methoxy or ethoxy group; amino and substituted amino groups, especially an amino, dimethylamino, diethylamino or di(β-hyα_roxyethyl)amino group; aminoalkyl and substituted aminoalkyl groups, especially an aminomethyl or dimethylaminomethyl group; a carboxylic acid group; or a suiphonic acid group.
The transition metal M is preferably iron, manganese or chromium.
Each not-π-ligand is preferably selected from carbonyl, phosphine, isocyanide, nitrosyl, bipyridine, phenanthroline or dithiolate groups. The first four such groupr ".re monovalent, while the last three such groups are divalent.
In one preferred form of the invention, the transition metal half-sandwich compound is employed as an inclusion complex in β-cyclodextrin, which typically takes the form of a 1 : 1 adduct.
The transition metal half-sandwich compounds are generally known or can be made by modified literature methods.
A particular advantage of transition metal half-sandwich complexes over the ferrocenes is that the greater degree of structural possibilities allows their properties to be tailored more closely to fit a particular enzyme application and/or biosensor configuration. Other applications and advantages of the present invention will be apparent, such as the possibility of the use of transition metal half-sandwich complexes as mediators to oxidoreductase enzymes, such as the generality of the flavoprotein, metalloprotein and quinoprotein oxidoreductases; also to act as mediators to redox proteins such as haemoglobin or to respiratory or other electron transfer redox proteins; the possibility of their use as labels for antigens or antibodies in immunochemical procedures including such as described in EP 125139-A; the possibility of their use as artificial substrates to monitor enzyme reactions with redox potentials modified by reaction with the enzyme; the possibility of tailoring the redox potential of a mediator by careful choice of ligands such that it may interact with a particular oxidoreductase protein but not with another; the use of the wider substitution chemistry of half sandwich complexes to fabricate enzyme-mediator complexes or modified electrodes; and other applications in the field of electrochemistry and bioelectrochemistry which will be apparent to the skilled person.
The preferred amperometric enzyme sensor adopting a transition metal half- sandwich compound as mediator utilizes a strip test element, especially a throw-away dry strip. For preference, a disposable test element carries a working electrode, the test reagents comprising at least the oxidoreductase enzyme and transition metal half-sandwich mediator compound for generation of a current indicative of the level of analyte, and a reference electrode. Typically, in the test element, the test reagents are in one or more carbon-based layers associated with the working electrode. Accordingly, the sensor electrodes preferably comprise electrode areas formed for instance by screen printing, spraying, or other suitable deposition technique.
For preference, respective carbon mixtures are applied on to a conductive track on a carrier, for example in close proximity to a reference electrode mixture connected to a second track. In this way, a sensor is produced which is capable of functioning with a small sample of whole blood or other liquid covering the effective electrode areas. The mixtures are most suitably applied to the carrier by screen printing. In a particularly preferred embodiment, the present invention provides a dry strip sensor which comprises an elongate, electrically-insulating carrier having a pair of longitudinal, substantially parallel electrically-conducting tracks thereupon, each track being provided at the same end with i.. «≤ans for electrical connection to a read-out means and provided with an electrode, one of the electrodes being the reference electrode and the other being the working electrode, together with test reagents.
More especially, such a sensor is configured in the form of a supporting strip of electrically insulating carrier material such as a synthetic polymer (for instance pvc) carrying at a location between its ends the two electrodes supported on electrically conductive printed tracks. For example, the electrodes can take the form of two rectangular areas side by side on the carrier strip. Such areas can be configured as a target area to be covered by a single drop of sample, such as whole blood, for testing for an analyte. If desired, non-rectangular electrode areas, for instance diamond-shaped, semicircular, or triangular areas, can be employed to provide a target area for optimised contact by a liquid sample.
The carrier carries at least two electrodes, namely a reference electrode and a working electrode, but may carry further electrodes such as a counter electrode and/or a dummy electrode, which is of similar formulation to the working electrode with associated test reagents, but lacks one or more of its active components. Such a dummy third electrode can lead to more reliable results, in that if charge passed at the third electrode is subtracted from charge passed at the working electrode, then the resulting charge is solely due to the reaction of interest.
A membrane may be provided at and above the target to perform a filtration function, for example to filter blood cells from the sample before it enters the test strip. As an alternative, a filtration or cellular separation membrane might be cast in situ.
In a more particularly preferred embodiment, there is provided a single use disposable electrode strip for attachment to signal readout circuitry of a sensor system to detect a current representative of a compound in a liquid mixture, the strip comprising: a) an elongated support adapted for releasable attachment to the readout circuitry; b) a first conductor extending along the support and comprising a conductive element for connection to the readout circuitry; c) an active electrode on the strip in contact with the first conductor and positioned to contact the mixture, the active electrode comprising a printed layer on the support, the printed layer comprising an enzyme capable of catalyzing a reaction involving a substrate for the enzyme and a transition metal half-sandwich mediator capable of transferring electrons transferred between the enzyme-catalyzed reaction and the first conductor to create a current representative of the activity of the enzyme and representative of the compound, the printed layer having an area less than 25 square mm; d) a second conductor extending along the support, comprising a conductive element for connection to the readout circuitry; and e) a reference electrode in contact with the second conductive element and positioned to contact the mixture and the second conductor, the first conductive element and the active electrode being spaced apart from the second conductive element and the reference electrode, and the electrodes being sized and positioned to present a combined effective area small enough to be completely coverable by a drop of blood, whereby the blood completes an electrical circuit across the active electrode and the reference electrode, for amperometric detection of the activity of the enzyme.
The test strips of this invention can detect analytes for example by known mediated enzyme electrochemical reactions, but using a transition metal half-sandwich compound as mediator. In this respect, the reader is referred to European Patent 78636-A, especially for its mention of glucose oxidase, as well as European Patent 127958-A and European Patent Specification 125137-A. Other enzymes for use with the present mediators include combinations of cholesterol oxidase, a peroxidase and optionally cholesterol esterase, for detection of free or total cholesterol, as described in European Patent 230786-A; and more generally systems including oxidoreductase or other enzymes, including flavoproteins, quinoproteins, and metalloproteins, and one or more mediator compounds, for example as described in European Patent Specification 125137-A. Other enzyme systems suitable for use in devices according to the present invention include oxidoreductases using nicotinamide and adenine dinucleotide and nicotinamide adenine dinucleotide phosphate as cofactors, for example those described in European Patent 125867-A; or systems using more than one enzyme, as described in European Patent 125136- A.
Test strips according to this invention are intended for use with electronic apparatus and meter systems. These control the progress of the electrochemical reaction, for example by maintaining a particular potential at the electrodes, and monitor the reaction and calculate and present the result. A particular feature which is desirable in a meter system for use with test strips of this type is the capability to detect the wetting of the reaction zone by sample fluid; this allows timely initiation of the measurement and reduces the scope for inaccuracies caused by user error. It is possible to achieve this goal by applying a potential to the electrodes of the test strip as soon as it is inserted into the meter; this potential is maintained until a certain threshold current is measured which will reflect the wetting of the reaction zone by sample fluid. The potential may then be removed for a short time to allow wetting to V completed before initiation of measurement in the usual way.
A further feature which is advantageous is the facility to ascertain automatically the identity of test strips for the measurement of different analytes. This might be achieved, for example, by the provision of additional contacts on the test strip in a pattern characterising the type of strip; the meter would have contact pads to determine the presence or absence of each contact. Alternatively, a system is possible using one or more additional circuit loops printed on the test strip of determined resistance characteristic of the type of strip, as described in US 5126034 at column 4, lines 3 to 17. As a further alternative, notches or other shapes might be made in the proximal end of the test strip which is inserted into the meter; switches or optical detectors in the meter can detect the presence or absence of each notch. Further possibilities for recognition of strip types include varying the colour of the strips and providing the meter with a photodetector capable of distinguishing the range of colours; also providing the strips with barcodes; magnetic stripes or other markings and providing the meter with a suitable reading arrangement.
A preferred technique for large scale production of test strips of the invention will be described. In this instance, the strip electrodes have a three-electrode configuration comprising a reference electrode, a working electrode, and a dummy electrode.
The carrier can be made from any material which has an electrically insulating surface including poly(vinyl chloride), polycarbonate, polyester, paper, cardboard, ceramic, metal coated with ceramic or other insulating substance. Poly( vinyl chloride) or a blend of polycarbonate/polyester seems to be particularly suitable.
A sheet of carrier material is cut to size using a punch tool which crops the outer edges at the same time as punching a number of registration holes. It is advantageous to use these holes during subsequent operations, but it is also feasible to edge-register throughout the process.
A conductive ink is applied to the carrier by a method of deposition such as screen printing. The punched holes are used to register the carrier. This layer produces the contact areas which allow a meter to interface with the test strip and provides an electrical circuit between the contacts and the active chemistry occurring on the strip. For preference, the ink is an organic solvent-based carbon mixture which is air-dried. Alternative formulations are possible including water-based inks and silver inks. Other methods of drying or curing the inks include infra-red, ultra-violet and radio- frequency radiation.
A layer forming the reference electrode is then printed with an organic solvent-based ink containing a silver/silver chloride mixture. The print extends to partially cover the middle track of the carbon print where it extends into the reaction zone. It is useful if separate parts of this print are extended to cover parts of the other carbon tracks outside the reaction zone so that the total electrical resistance of each track is reduced. A layer of dielectric ink may optionally be printed to cover the majority of the printed carbon and silver/silver chloride layers. In this case, two areas are left uncovered, namely the electrical contact areas and the sensing area which will underlie the reactive zone. This print serves to define the area of the reactive zone, and to protect exposed tracks from short circuit.
For the working electrode, one or more inks are deposited to a precise thickness within a defined area on top of one of the conductive tracks within the reaction zone, to deposit the enzyme and the half-sandwich mediator compound. It is convenient to do this by means of screen printing. Other ways of laying down this ink include inkjet, volumetric dosing, gravure printing, flexographic printing, and letterpress printing.
Optionally, a second partially active ink forming a dummy electrode can be deposited on a remaining conductive track, such that each active ink lies on a conducting track equidistant from a central track coated with the silver/silver chloride ink.
EXAMPLES OF THE INVENTION
The present invention will now be further described by way of non-limiting examples.
All reactions and subsequent manipulations involving organometallic reagents were performed under anaerobic and anhydrous conditions using an atmosphere of nitrogen. Chromium hexacarbonyi and methylcyclopentadienyl manganese tricarbonyl were obtained from Strem Chemicals, Inc. 1,10-Phenanthroline, 2,2'-bipyridine, β-cyclodextrin hydrate, dimethyldi thi. carbamic acid, diethyldithiocarbamic acid and 4- morpholine arbodi o c acid were purchased from Aldrich Chemicals. Disodium cis 1,2-dκ dnoethylene-l,2-dithiolate was prepared by a published method (Inorg. Chem., 5 (1966) 1157). The product compounds were designated by Compound numbers, as in "Compound 6".
The phosphate buffer solution (PBS) of 0.15 M phosphate (with 0.2 M sodium chloride as supporting electrolyte), pH 7.0, containing 0.1 M glucose was prepared using Analar reagents from Merck BDH. The solution was stored overnight at 4°C prior to use to allow equilibration of the - and β- anomers. Glucose oxidase (EC 1.1.3.4 from Aspergillus niger) was supplied by Sturge Enzymes. Horseradish peroxidase was obtained from Biozyme.
In the Examples, reference is made to the accompanying figures of the drawings.
SUMMARY OF THE DRAWINGS
Figure 1 is a cyclic voltammogram of the chromium complex Compound 6.
Figure 2 comprises (a) cyclic voltammograms of electrodes containing the chromium complex Compound 6, and (b) the catalytic wave upon addition of glucose oxidase.
Figure 3 shows catalytic waves obtained on titrating glucose oxidase with the manganese complex Compound 8.
Figure 4 is a graphical plot of data obtained from the catalytic waves of Figure 3.
Figure 5 is a cyclic voltammogram of the manganese complex Compound 16.
Figure 6 comprises (a) a cyclic voltammogram of the β-cyclodextrin adduct of the manganese complex Compound 10, and (b) the catalytic wave upon addition of glucose oxidase. Figure 7 comprises cyclic voltammograms of the manganese complex Compound 16 in the presence of different amounts of β-cyclodextrin.
Figure 8 comprises cyclic voltammograms of electrodes containing the manganese complexes (a) Compound 10, (b) Compound 1 1 , and (c) Compound 12.
Figure 9 comprises (a) cyclic voltammograms of electrodes containing the manganese complex Compound 10, and (b) the catalytic wave upon addition of glucose oxidase.
Figure 10 shows the response to glucose of poised glucose oxidase/Compound 10 electrodes.
Example 1
Arene chromium tricarbonyl complexes were prepared by refluxmg the appropriate arene with Cr(CO)6 in refluxmg di-n-butyl ether/tetrahydrofuran (10:1) according to a general literature procedure (Inorg. Synth., 19 (1979) 154). [MeCpMn(NO)(CO)2]PF6 Compound 9 was prepared by the procedure of King and Bisnel .-_ Inorg. Chem., 6 (1967) 469). Literature methods were used for the syv* esis of [MeCpMn(NO)(CN)2]Na Compound 13 (J. Organomet. Chem., 170 (1979) 217), [MeCpMn(NO)(bipy)]PF6 Compound 14 (Inorg. Chem., 8 (1969) 1340), [MeCpMn(NO)(phen)]PF6 Compound 15 (Inorg. Chem., 8 (1969) 1340), [MeCpMn(NO)(S2CNMe2)] Compound 10 (Inorg. Chem., 8 (1969) 1340), [MeCpMn(NO)(S2CNEt2)] Compound 11 (Inorg. Chem., 8 (1969) 1340), and [MeCpMn(NO){(SCCN)2}][NEt4] Compound 16 (Inorg. Chem., 8 (1969) 1340).
r I
Preparation of [MeCpMn NO)(S2CNCH2CH2θCH2CH2)] Compound 12:
The salt [MeCpMn(NO)(CO)2]PF6 Compound 9 (1.5 g, 4.1 mmol) was dissolved in warm, degassed acetone (45 ml). The stirred solution was treated with a mixture of 4-morpholinecarbodithioic acid (1.03 g, 4.1 1 mmol) in 50 ml ethanol/acetone (1 : 1) and 15 ml water. A colour change to red-brown was observed together with the liberation of carbon monoxide gas. Stirring was continued for 2 hours at 45°C. Filtration yielded a solution from which a crude black-brown product was obtained by reduction of the solvent volume in vacuo followed by cooling. The resulting precipitate was filtered off and recrystallised from boiling petroleum ether (40-60°C)/acetone, giving brown needles of Compound 12 (0.2g, 15%)] after storage at -20°C for 3 days.
Melting point: 1 12-1 13°C
Analysis:
Found: C,40.78; H,4.70; N,8.53.
Calc for C] \ \ 5N2θ2S2Mn: C,40.49; H,4.63; N,8.58
Preparation of [MeCpMn(NO)(S2CNMe2)]β-cyclodextrin:
The procedure used was adapted from a reported method for the preparation of ferrocene-β-cyclodextrin adducts (J. Chem. Soc. Dalton Trans, (1991) 2749).
β-Cyclodextrin hydrate (2.50 g, 2.2 mmol) was dissolved in water (25 ml) at 70°C under nitrogen. Solid [MeCpMn(NO)(S2CNMe2)] Compound 10 (0.284 g, 1.0 mmol) was then added and the resulting mixture was stirred and heated at 70°C for 7 hours. Upon cooling, the precipitate was filtered off and washed copiously with water followed by ethanol and diethyl ether. The required adduct (0.405 g) was obtained as a brown powder, melting point 300°C with decomposition. Initial microanalysis results on the crude product indicate that it is a 1 :1 adduct containing several molecules of water of crystallisation.
Example 2 The half wave potential of benzene chromium tricarbonyl has been recorded as +710mV vs SCE in dichloromethane (J. Chem Soc. Dalton Trans., (1973) 1768). This complex has negligible solubility in buffer. Derivatives, however, are simple to prepare in good yield using the thermolysis of chromium hexacarbonyl with substituted benzenes in tetrahydrofuran/di-n- butyl ether (Inorg. Synth., 19 (1979) 154). Arenes containing amines directly attached to the ring were selected in the hope of enhancing the aqueous solubility of the resulting complexes as well as reducing their mid¬ point potentials. A series of seven complexes were investigated and were found to demonstrate aqueous electrochemistry in the region +280 to +40mV, as shown in the following table.
Figure imgf000017_0001
Figure 1 is a cyclic voltammogram of th , . romium complex Compound 6, at 50 mV/s in PBS. Compound 6 was - . only compound to display a reversible wave, as shown Figure 1, though it was poorly soluble in aqueous buffer. Further studies were confined to Compound 6.
Example 3
Screen-printed electrodes incorporating Compound 6 were produced from an organic carbon ink containing the chromium complex at a level of 3.5 mg/g ink. Figure 2 comprises (a) cyclic voltammograms of electrodes containing the chromium complex Compound 6 at 50 mV/s and 0.2 uA/cm in PBS, and (b) the catalytic wave upon addition of 100 μl glucose oxidase recorded at 20 mV/s and 0.5 μA/cm. It will be seen from Figure 2(a) that a reversible wave was recorded when PBS was applied to the electrodes, but at a lower mid-point potential of - 15 mV. From Figure 2(b), it is seen that GOD mediation occurs on applying mixtures of enzyme and glucose to the electrodes, with small catalytic currents of about 1 μA.
The result is significant since it demonstrates that it is possible to use a very hydrophobic complex to mediate to GOD when it is incorporated in a carbon electrode. It also illustrates the potential of transition metal half-sandwich complexes as mediators.
Example 4
Manganese half-sandwich complexes can be obtained from (methylcyclopentadienyl)manganese tricarbonyl Compound 8, an inexpensive and readily available starting material due to its large scale use as an anti-knocking additive in unleaded petrol. For example, as shown in the following reaction scheme, access to a wide and varied carbonyl substitution chemistry is provided via the nitrosyl cation Compound 9 produced by treatment of the tricarbonyl compound Compound 8 with nitrous acid (Inorg. Chem., 6 (1967) 469) or nitrosonium ion (J. Organomet. Chem, 56 (1973) 345).
Reaction Scheme:
Figure imgf000019_0001
Cyclopentadienyl manganese tricarbonyl itself is more difficult to oxidise than ferrocene; its oxidation potential being some 1.2 V more positive than ferrocene in acetonitrile (J. Organomet. Chem., 101 (1975) C43). The nitrosyl cation Compound 9 readily decomposes in aqueous buffer to give a species which is irreversibly oxidized at +230 mV. However, treatment of Compound 8 with cyanide ion (J. Organomet. Chem., 170 (1979) 217) affords the anionic dicyano complex Compound 13 which is highly water soluble and displays a reversible wave at +440 mV. Figure 3 shows catalytic waves obtained at 5 mV/s and 5 μA/cm on titrating glucose oxidase with the manganese complex Compound 8, using 0 to 25 μl GOD titrated into a solution of Compound 8 in 0.1 M glucose/PBS. A series of catalytic waves of increasing amplitude were obtained. A second order rate coefficient for the oxidation of reduced GOD of 2.1 x 10-5 M~ls~l was derived from the graph shown in Figure 4 of icat versus [GOD]1/2 plotted according to literature methods (Prog. React. Kinet., 16 (1991) 55, and J. Electroanal. Chem., 293 (1990) 55). This rate constant compares very favourably with those determined for ferrocenes, such as 2.0 x \0~ M"^ s~-- for ferrocene monocarboxylic acid (Anal. Chem., 56 (1984) 667).
Example 5
Several other manganese half-sandwich compounds were prepared from Compound 9. Treatment of Compound 9 with the bidentate ligands 2,2,- bibyridine and 1,10-phenanthroline in accordance with a literature method (J. Chem. Soc (A), (1970) 850) afforded the cation Compounds 14 and 15, respectively. Both complexes exhibited irreversible electrochemistry at potentials of about +600 mV.
Compound 16 was prepared from cis-l,2-dicyanoethylene-l,2-dithiolate (Inorg. Chem., 8 (1969) 1340). Figure 5 is a cyclic voltammogram of the manganese complex Compound 16 0.6 mM in PBS at 50 mV/s and 2 μ A/cm. A much lower Eox of -25 mV was observed for the anionic dithiolene complex, but the oxidized form (a neutral species) proved to be insoluble in buffer. The resultant coating of the electrode meant that an enzyme titration was not possible.
The dithiocarbamate complexes Compounds 10 and 11 were prepared according to the literature method (Inorg. Chem., 8 (1969) 1340) which was also used to prepare the morpholinodithiocarbamate complex Compound 12, a new compound. Compounds 10 to 12 were all found to have negligible solubility in buffer thereby preventing any observation of their electrochemistry. Example 6
The literature abounds with papers describing the inclusion of ferrocenes into the hydrophobic activity of β-cyclodextrin (β-cd) resulting in a change in their physical properties not the least of which is an increase in their aqueous solubilities. A slight positive shift in the mid-point potentials of ferrocenes incorporated in β-cd has been reported (J. Org. Chem., 56 (1991) 35, Bioelectrochem. Bioenerg., 24 (1990) 257) and an inhibition by β-cd of the mediation of ferrocenes with GOD. There does not seem to be any report of β-cd hosting a manganese complex.
It was found that simply stirring the solid complex Compound 10 in an aqueous solution of β-cd at 70°C resulted in the formation of a linclusion complex which precipitated upon cooling of the mixture. The inclusion complex is soluble in PBS, to at least 0.5 mM. Figure 6 comprises (a) a cyclic voltammogram of the β-cyclodextrin adduct of the manganese complex Compound 10 in 0.1 M glucose/PBS, and (b) the catalytic wave upon addition of 50 μl glucose oxidase. The inclusion complex displays a reversible wave at +255 mV with ΔEp = 70 mV, and catalytic wave with •cat = 9.7μA is observed upon addition of GOD and glucose.
Example 7
Having demonstrated that β-cd is capable of hosting a neutral manganese half sandwich complex, it was also found that β-cd might act as a solubilising agent for the insoluble oxidized form of the anionic complex Compound 16 mentioned earlier. The cyclic voltammogram of a 0.5 mM solution of Compound 16 in buffer has features which indicate that a species is being precipitated onto the electrode. However, addition of β-cd (0.5- 5.0mM) resulted in a reversible wave. Figure 7 comprises cyclic voltammograms of the manganese complex Compound 16 in the presence of different amounts of (a) PBS only, and PBS containing (b) 0.5 mM β-cd, (c) 1.0 mM β-cd, and (d) 5.0 mM β-cd. The wave shows E'/_ = +5mV and Δ Ep = 65mV.
Example 8
Further work with the dithiocarbamate complexes Compounds 10 to 12 was carried out with screen-printed carbon electrodes produced from carbon inks mixed with each of the complexes. As shown in Figure 8, oxidation waves were observed at +240, +300 and +290 mV for (a) Compound 10, (b) Compound 11, and (c) Compound 12, respectively, using scan rates of 50 and 100 mV/s at 0.5 μA/cm. Catalytic currents in the region of 4 μA were recorded in the presence of GOD and glucose. Variable but increased currents of up to 29 μA were obtained with 0.1 M glucose when the enzyme was confined in the carbon electrode with the mediator, see Figure 9.
These mediator/enzyme electrodes responded linearly as shown in Figure 10 to glucose in the range 0 to 12 mM when poised at +450 mV. Inclusion of ethylene glycol in the formulation of the carbon ink containing enzyme gave currents of up to 190 μA with 0.1 M glucose.
Example 9
The ability of the β-cyclodextrin adduct of the manganese complex Compound 10 to mediate with horseradish peroxide (HRP) was assessed by comparing it with l,r-dimethylferrocene ethanolamine using rotating ring- disk voltammetry according to a literature method (Anal. Chem., 62 (1990) 2429). Experiments were carried out using a glass cell (14 ml capacity) containing a platinum counter electrode with a calomel reference electrode. A gold-gold ring-disk electrode, rotated at 4 Hz, was immersed in a phosphate-buffered saline solution of the mediator (0.5 mM) containing HRP (280 U). The catalytic ring current was then measured while poising the ring electrode at -100 mV and scanning the disk electrode from -100 to - 600m V to generate hydrogen peroxide. Successive experiments with the ferrocene and the β-cd adduct of Compound 10 resulted in identical catalytic currents being recorded.

Claims

1. A process of mediating electron transfer between an electrode and an oxidoreductase enzyme or other electron transfer redox protein using a mediator compound, wherein said mediator compound is a half-sandwich complex of a transition metal, said complex having a single π-ligand with delocalised π bonding.
2. The process of claim 1, wherein said half-sandwich mediator compound is a complex of the general formula:
(π-ligand)M(not-π-ligand)n wherein the complex may be charged or neutral, π-ligand represents the single π-bonded ligand, M represents the transition metal atom, n is the number of ligands which are not π-ligands, and the n not-π-ligands are the same or different, are univalent or multivalent, and serve to satisfy the valency of the transitional metal M.
3. The process of claim 2, wherein the π-ligand is selected from the group consisting of an allyl group, a cyclopropenyl group, a cyclobutadiene group, a cyclopentadienyl group, a benzene group, a cycloheptatrienyl group or a trimethylenemethane group.
4. The process of claim 2, wherein the π-ligand has 1 to 4 substituents selected from the group consisting of alkyl groups, alkoxy groups, amino and substituted amino groups, aminoalkyl and substituted aminoalkyl groups, a carboxylic acid group; and a sulphonic acid group.
5. The process of claim 2, wherein the transition metal M is iron, manganese or chromium.
6. The process of claim 2, wherein each not-π-ligand is selected from the group consisting of carbonyl, phosphine, isocyanide, nitrosyl, bipyridine, phenanthroline and dithiolate groups.
7. The process of claim 1, wherein the transition metal half-sandwich compound is employed as an inclusion complex in β-cyclodextrin.
8. An amperometric enzyme sensor for an analyte, which sensor employs a transition metal half-sandwich compound as mediator.
9. A disposable dry strip test element for an amperometric enzyme sensor, said disposable test element carrying a working electrode, test reagents comprising at least an oxidoreductase enzyme and a transition metal half-sandwich mediator compound for generation of a current indicative of the level of analyte, and a reference electrode.
10. An electrically conductive printing ink which includes a transition metal half-sandwich mediator compound.
PCT/GB1993/001179 1992-06-05 1993-06-03 Mediators to oxidoreductase enzymes WO1993025898A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP93913284A EP0598095A1 (en) 1992-06-05 1993-06-03 Mediators to oxidoreductase enzymes
JP50123994A JP3288044B2 (en) 1992-06-05 1993-06-03 Mediator for oxidoreductase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9212010.4 1992-06-05
GB929212010A GB9212010D0 (en) 1992-06-05 1992-06-05 Mediators to oxidoreductase enzymes

Publications (1)

Publication Number Publication Date
WO1993025898A1 true WO1993025898A1 (en) 1993-12-23

Family

ID=10716653

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1993/001179 WO1993025898A1 (en) 1992-06-05 1993-06-03 Mediators to oxidoreductase enzymes

Country Status (5)

Country Link
EP (1) EP0598095A1 (en)
JP (1) JP3288044B2 (en)
CA (1) CA2115052A1 (en)
GB (1) GB9212010D0 (en)
WO (1) WO1993025898A1 (en)

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998057158A1 (en) * 1997-06-12 1998-12-17 Clinical Micro Sensors, Inc. Detection of analytes using reorganization energy
US6977151B2 (en) 1996-11-05 2005-12-20 Clinical Micro Sensors, Inc. Electrodes linked via conductive oligomers to nucleic acids
US7056669B2 (en) 1996-11-05 2006-06-06 Clinical Micro Sensors, Inc. AC methods for the detection of nucleic acids
US7384749B2 (en) 1996-11-05 2008-06-10 Clinical Micro Sensors, Inc. Electrodes linked via conductive oligomers to nucleic acids
US7935481B1 (en) 1999-07-26 2011-05-03 Osmetech Technology Inc. Sequence determination of nucleic acids using electronic detection
USRE44695E1 (en) 2003-12-05 2014-01-07 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8690796B2 (en) 2002-04-19 2014-04-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
WO2014114810A1 (en) 2013-01-28 2014-07-31 Roche Diagnostics Gmbh Novel glucose oxidases derived from aspergillus niger
US8845549B2 (en) 2002-04-19 2014-09-30 Sanofi-Aventis Deutschland Gmbh Method for penetrating tissue
US8845550B2 (en) 2001-06-12 2014-09-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8877035B2 (en) 2005-07-20 2014-11-04 Bayer Healthcare Llc Gated amperometry methods
US8905945B2 (en) 2002-04-19 2014-12-09 Dominique M. Freeman Method and apparatus for penetrating tissue
US8945910B2 (en) 2003-09-29 2015-02-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9005527B2 (en) 2006-10-24 2015-04-14 Bayer Healthcare Llc Transient decay amperometry biosensors
US9034639B2 (en) 2002-12-30 2015-05-19 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US9089294B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9089678B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9110013B2 (en) 2005-09-30 2015-08-18 Bayer Healthcare Llc Gated voltammetry methods
US9144401B2 (en) 2003-06-11 2015-09-29 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US9261476B2 (en) 2004-05-20 2016-02-16 Sanofi Sa Printable hydrogel for biosensors
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9451908B2 (en) 2006-10-04 2016-09-27 Dexcom, Inc. Analyte sensor
US9504413B2 (en) 2006-10-04 2016-11-29 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US9560993B2 (en) 2001-11-21 2017-02-07 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9561000B2 (en) 2003-12-31 2017-02-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9839386B2 (en) 2002-04-19 2017-12-12 Sanofi-Aventis Deustschland Gmbh Body fluid sampling device with capacitive sensor
US10980461B2 (en) 2008-11-07 2021-04-20 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US11000215B1 (en) 2003-12-05 2021-05-11 Dexcom, Inc. Analyte sensor
US11382539B2 (en) 2006-10-04 2022-07-12 Dexcom, Inc. Analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0309905D0 (en) * 2003-04-30 2003-06-04 E2V Technologics Ltd Electrochemical sensing assays
JP5334136B2 (en) * 2009-09-09 2013-11-06 独立行政法人産業技術総合研究所 Electrochemical molecular recognition probe, molecular recognition sensor using the same, and electrochemical detection method using them
CN112795243B (en) * 2020-12-31 2022-10-04 德莱森(北京)医疗科技有限公司 Application of medium structure in conductive ink functional material

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127958A2 (en) * 1983-05-05 1984-12-12 MediSense, Inc. Sensor electrode systems
EP0150602A2 (en) * 1983-12-20 1985-08-07 Genetics International, Inc. Carbon-boron compounds in electron transfer electrodes
EP0230786A1 (en) * 1985-12-24 1987-08-05 MediSense, Inc. Assay for cholesterol and derivatives thereof
WO1992004466A1 (en) * 1990-09-01 1992-03-19 Environmental & Medical Products Ltd Electrochemical biosensor stability

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127958A2 (en) * 1983-05-05 1984-12-12 MediSense, Inc. Sensor electrode systems
EP0150602A2 (en) * 1983-12-20 1985-08-07 Genetics International, Inc. Carbon-boron compounds in electron transfer electrodes
EP0230786A1 (en) * 1985-12-24 1987-08-05 MediSense, Inc. Assay for cholesterol and derivatives thereof
WO1992004466A1 (en) * 1990-09-01 1992-03-19 Environmental & Medical Products Ltd Electrochemical biosensor stability

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DENISOVICH L.I. ET AL.: "Oxidation of pi-C5H5M(CO)3 (M=Mn, Re) and their Derivatives", JOURNAL OF ORGANOMETALLIC CHEMISTRY, LAUSANNE CH, vol. 101, no. 3, 25 November 1975 (1975-11-25), pages C43 - C44, XP000654412, DOI: doi:10.1016/S0022-328X(00)92480-X *
HENDRY S.P. ET AL.: "Amperometric Biosensors", JOURNAL OF BIOTECHNOLOGY, AMSTERDAM NL, vol. 15, no. 3, August 1990 (1990-08-01), pages 229 - 238 *
LLOYD M.K. ET AL.: "Voltammetric Oxidation of Arene, Cycloheptatriene, and Cycloheptatrienyl Tricarbonyl Complexes of Chromium", JOURNAL OF THE CHEMICAL SOCIETY, DALTON TRANSACTIONS, LETCHWORTH GB, vol. 1973, no. 17, 1973, pages 1768 - 1770, XP000654403, DOI: doi:10.1039/dt9730001768 *
MCCLEVERTY J.A. ET AL.: "Transition Metal Dithiolene Complexes. IX. Manganese pi-Cyclopentadienyl(nitrosyl)dithiolene and Related Metal Complexes", INORGANIC CHEMISTRY, EASTON US, vol. 8, no. 6, June 1969 (1969-06-01), pages 1340 - 1347, XP000654386, DOI: doi:10.1021/ic50076a028 *
RAHIMAH ISNIN ET AL.: "Bimodal Cyclodextrin Complexation of Ferrocene Derivatives Containing n-Alkyl Chains of Varying Length", JOURNAL OF ORGANIC CHEMISTRY, EASTON US, vol. 56, no. 1, 4 January 1991 (1991-01-04), pages 35 - 41, XP000654411, DOI: doi:10.1021/jo00001a009 *
REGER D.L. ET AL.: "Preparation of New (Eta5-C5H4CH3)Mn(NO)(PPh3) and (Eta7-C7H7)Mo(CO)(PPh3) Complexes", JOURNAL OF ORGANOMETALLIC CHEMISTRY, LAUSANNE CH, vol. 170, no. 2, May 1979 (1979-05-01), pages 217 - 227, XP000654405, DOI: doi:10.1016/S0022-328X(00)81086-4 *

Cited By (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056669B2 (en) 1996-11-05 2006-06-06 Clinical Micro Sensors, Inc. AC methods for the detection of nucleic acids
US7384749B2 (en) 1996-11-05 2008-06-10 Clinical Micro Sensors, Inc. Electrodes linked via conductive oligomers to nucleic acids
US6977151B2 (en) 1996-11-05 2005-12-20 Clinical Micro Sensors, Inc. Electrodes linked via conductive oligomers to nucleic acids
US7514228B2 (en) 1997-06-12 2009-04-07 Clinical Micro Sensors, Inc. Detection of analytes using reorganization energy
US7267939B2 (en) 1997-06-12 2007-09-11 Clinical Micro Sensors, Inc. Detection of analytes using reorganization energy
US6013459A (en) * 1997-06-12 2000-01-11 Clinical Micro Sensors, Inc. Detection of analytes using reorganization energy
WO1998057158A1 (en) * 1997-06-12 1998-12-17 Clinical Micro Sensors, Inc. Detection of analytes using reorganization energy
US7935481B1 (en) 1999-07-26 2011-05-03 Osmetech Technology Inc. Sequence determination of nucleic acids using electronic detection
US9694144B2 (en) 2001-06-12 2017-07-04 Sanofi-Aventis Deutschland Gmbh Sampling module device and method
US9937298B2 (en) 2001-06-12 2018-04-10 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8845550B2 (en) 2001-06-12 2014-09-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9802007B2 (en) 2001-06-12 2017-10-31 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9560993B2 (en) 2001-11-21 2017-02-07 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9724021B2 (en) 2002-04-19 2017-08-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9072842B2 (en) 2002-04-19 2015-07-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8905945B2 (en) 2002-04-19 2014-12-09 Dominique M. Freeman Method and apparatus for penetrating tissue
US9498160B2 (en) 2002-04-19 2016-11-22 Sanofi-Aventis Deutschland Gmbh Method for penetrating tissue
US9907502B2 (en) 2002-04-19 2018-03-06 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9839386B2 (en) 2002-04-19 2017-12-12 Sanofi-Aventis Deustschland Gmbh Body fluid sampling device with capacitive sensor
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9089294B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9089678B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8845549B2 (en) 2002-04-19 2014-09-30 Sanofi-Aventis Deutschland Gmbh Method for penetrating tissue
US9339612B2 (en) 2002-04-19 2016-05-17 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9186468B2 (en) 2002-04-19 2015-11-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US8690796B2 (en) 2002-04-19 2014-04-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9034639B2 (en) 2002-12-30 2015-05-19 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US9144401B2 (en) 2003-06-11 2015-09-29 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US10034628B2 (en) 2003-06-11 2018-07-31 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US8945910B2 (en) 2003-09-29 2015-02-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
US8929968B2 (en) 2003-12-05 2015-01-06 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8911369B2 (en) 2003-12-05 2014-12-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US11020031B1 (en) 2003-12-05 2021-06-01 Dexcom, Inc. Analyte sensor
US11000215B1 (en) 2003-12-05 2021-05-11 Dexcom, Inc. Analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US9579053B2 (en) 2003-12-05 2017-02-28 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US10299712B2 (en) 2003-12-05 2019-05-28 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US10188333B2 (en) 2003-12-05 2019-01-29 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
USRE44695E1 (en) 2003-12-05 2014-01-07 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US9561000B2 (en) 2003-12-31 2017-02-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US9261476B2 (en) 2004-05-20 2016-02-16 Sanofi Sa Printable hydrogel for biosensors
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US8877035B2 (en) 2005-07-20 2014-11-04 Bayer Healthcare Llc Gated amperometry methods
US11435312B2 (en) 2005-09-30 2022-09-06 Ascensia Diabetes Care Holdings Ag Devices using gated voltammetry methods
US10670553B2 (en) 2005-09-30 2020-06-02 Ascensia Diabetes Care Holdings Ag Devices using gated voltammetry methods
US9110013B2 (en) 2005-09-30 2015-08-18 Bayer Healthcare Llc Gated voltammetry methods
US9835582B2 (en) 2005-09-30 2017-12-05 Ascensia Diabetes Care Holdings Ag Devices using gated voltammetry methods
US10349873B2 (en) 2006-10-04 2019-07-16 Dexcom, Inc. Analyte sensor
US11382539B2 (en) 2006-10-04 2022-07-12 Dexcom, Inc. Analyte sensor
US10136844B2 (en) 2006-10-04 2018-11-27 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US11399745B2 (en) 2006-10-04 2022-08-02 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US9451908B2 (en) 2006-10-04 2016-09-27 Dexcom, Inc. Analyte sensor
US9504413B2 (en) 2006-10-04 2016-11-29 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US10190150B2 (en) 2006-10-24 2019-01-29 Ascensia Diabetes Care Holdings Ag Determining analyte concentration from variant concentration distribution in measurable species
US11091790B2 (en) 2006-10-24 2021-08-17 Ascensia Diabetes Care Holdings Ag Determining analyte concentration from variant concentration distribution in measurable species
US9005527B2 (en) 2006-10-24 2015-04-14 Bayer Healthcare Llc Transient decay amperometry biosensors
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
US10980461B2 (en) 2008-11-07 2021-04-20 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
WO2014114810A1 (en) 2013-01-28 2014-07-31 Roche Diagnostics Gmbh Novel glucose oxidases derived from aspergillus niger

Also Published As

Publication number Publication date
JPH06509877A (en) 1994-11-02
JP3288044B2 (en) 2002-06-04
EP0598095A1 (en) 1994-05-25
GB9212010D0 (en) 1992-07-15
CA2115052A1 (en) 1993-12-23

Similar Documents

Publication Publication Date Title
US5710011A (en) Mediators to oxidoreductase enzymes
JP3288044B2 (en) Mediator for oxidoreductase
AU743468C (en) Biosensor electrode mediators for regeneration of cofactors
CN1620462B (en) Transition metal complexes with (pyridyl) imidazole ligands
US6736957B1 (en) Biosensor electrode mediators for regeneration of cofactors and process for using
Garjonyte et al. Amperometric glucose biosensors based on Prussian Blue–and polyaniline–glucose oxidase modified electrodes
EP0140322B1 (en) Polymer catalyst transducers and use thereof in test kits for analytical methods
DE60035123T2 (en) TRANSITION METAL COMPLEXES BELONGED TO A POLYMER BY A MOVABLE INTERMEDIATE MEMBER
US7052591B2 (en) Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking
Alonso et al. Amperometric enzyme electrodes for aerobic and anaerobic glucose monitoring prepared by glucose oxidase immobilized in mixed ferrocene–cobaltocenium dendrimers
Forrow et al. Transition metal half-sandwich complexes as redox mediators to glucose oxidase
Jubete et al. Nanotechnology: A Tool for Improved Performance on Electrochemical Screen-Printed (Bio) Sensors.
Ivanova et al. Evaluation of redox mediators for amperometric biosensors: Ru-complex modified carbon-paste/enzyme electrodes
MX2008008104A (en) Redox mediators.
Cardoso et al. Biocathodes for enzymatic biofuel cells using laccase and different redox mediators entrapped in polypyrrole matrix
Shamsipur et al. Electrocatalytic activity of cobaloxime complexes adsorbed on glassy carbon electrodes toward the reduction of dioxygen
Armada et al. Electrodes modified with a siloxane copolymer containing interacting ferrocenes for determination of hydrogen peroxide and glucose
Berchmans et al. Layer-by-layer assembly of 1, 4-diaminoanthraquinone and glucose oxidase
Warren et al. Investigation of novel mediators for a glucose biosensor based on metal picolinate complexes
EP1801229B1 (en) Biosensor electrode
Garcí Armada et al. A siloxane homopolymer with interacting ferrocenes as a new material for the preparation of sensors based on the detection of hydrogen peroxide
Shi et al. Adsorption/Deposition of the Ligands 9, 10-Phenanthroline-5, 6-dione and 9, 10-Phenanthroline-5, 6-diol and Their Metal Complexes on Pyrolytic Graphite Electrodes
Nakabayashi et al. Dipolar ruthenium (II) ammine complexes as electron transfer mediators of amperometric glucose sensors
Dewi et al. Four-electron reduction of dioxygen catalyzed by a decavanadium complex
Koopal Third generation amperometric biosensors

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 1993 98375

Country of ref document: US

Date of ref document: 19930809

Kind code of ref document: A

AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 2115052

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1993913284

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1993913284

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 1995 400133

Country of ref document: US

Date of ref document: 19950306

Kind code of ref document: A

WWW Wipo information: withdrawn in national office

Ref document number: 1993913284

Country of ref document: EP